| Emerging strategies for EphA2 receptor targeting for cancer therapeutics M Tandon, SV Vemula, SK Mittal Expert opinion on therapeutic targets 15 (1), 31-51, 2011 | 294 | 2011 |
| Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover NK Prasad, M Tandon, S Badve, PW Snyder, H Nakshatri Carcinogenesis 29 (1), 25-34, 2008 | 119 | 2008 |
| Adenoviral vector-based strategies for cancer therapy A Sharma, M Tandon, DS Bangari, SK Mittal Current drug therapy 4 (2), 117-138, 2009 | 95 | 2009 |
| High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival NK Prasad, M Tandon, A Handa, GE Moore, CF Babbs, PW Snyder, ... Tumor Biology 29 (5), 330-341, 2008 | 89 | 2008 |
| Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells M Tandon, Z Chen, J Pratap Breast Cancer Research 16, 1-14, 2014 | 87 | 2014 |
| Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells M Tandon, K Gokul, SA Ali, Z Chen, J Lian, GS Stein, J Pratap Molecular cancer 11, 1-10, 2012 | 67 | 2012 |
| Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model A Sharma, DS Bangari, M Tandon, A Pandey, H HogenEsch, SK Mittal Virology 386 (1), 44-54, 2009 | 60 | 2009 |
| Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses A Sharma, M Tandon, YS Ahi, DS Bangari, R Vemulapalli, SK Mittal Gene therapy 17 (5), 634-642, 2010 | 53 | 2010 |
| The role of Runx2 in facilitating autophagy in metastatic breast cancer cells M Tandon, AH Othman, V Ashok, GS Stein, J Pratap Journal of cellular physiology 233 (1), 559-571, 2018 | 39 | 2018 |
| Role of Runx2 in IGF-1Rβ/Akt-and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis M Tandon, Z Chen, AH Othman, J Pratap Oncogene 35 (36), 4730-4740, 2016 | 38 | 2016 |
| Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model A Sharma, DS Bangari, M Tandon, H HogenEsch, SK Mittal Virus research 153 (1), 134-142, 2010 | 30 | 2010 |
| EphrinA1–EphA2 interaction‐mediated apoptosis and FMS‐like tyrosine kinase 3 receptor ligand‐induced immunotherapy inhibit tumor growth in a breast cancer mouse model M Tandon, SV Vemula, A Sharma, YS Ahi, S Mittal, DS Bangari, SK Mittal The Journal of Gene Medicine 14 (2), 77-89, 2012 | 23 | 2012 |
| Role of Runx2 in crosstalk between mek/erk and PI3K/akt signaling in MCF‐10A Cells M Tandon, Z Chen, J Pratap Journal of cellular biochemistry 115 (12), 2208-2217, 2014 | 21 | 2014 |
| Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer M Tandon, A Sharma, SV Vemula, DS Bangari, SK Mittal Virus research 163 (1), 202-211, 2012 | 18 | 2012 |
| Bone metastatic breast cancer: Advances in cell signaling and autophagy related mechanisms A Othman, M Winogradzki, L Lee, M Tandon, A Blank, J Pratap Cancers 13 (17), 4310, 2021 | 15 | 2021 |
| Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism M Tandon, AH Othman, M Winogradzki, J Pratap Gene 775, 145419, 2021 | 11 | 2021 |
| 5'-inositol phosphatase 2 (SHIP2) is over-expressed in endometrial cancer M Sever, M Tandon, N Prasad, S Badve Laboratory Investigation 86, 195A-195A, 2006 | 2 | 2006 |
| EphrinA1-EphA2 interaction-mediated apoptosis and Flt3L-induced immunotherapy inhibits tumor growth in a breast cancer mouse model M Tandon, SV Vemula, A Sharma, YS Ahi, S Mittal, DS Bangari, SK Mittal The journal of gene medicine 14 (2), 77, 2012 | 1 | 2012 |
